B. G. Nordestgaard, M. J. Chapman, S. E. Humphries, H. N. Ginsberg, L. Masana et al., Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society, Eur Heart J. 1 déc, vol.34, issue.45, pp.3478-90, 2013.

R. Henderson, M. O'kane, V. Mcgilligan, and S. Watterson, The genetics and screening of familial hypercholesterolaemia, J Biomed Sci, vol.23, issue.1

E. P. Walma, F. L. Visseren, and J. W. Jukema, The practice guideline 'Diagnosis and treatment of familial hypercholesterolaemia' of the Dutch Health Care Insurance Board

, Ned Tijdschr Geneeskd, vol.150, pp.18-23, 2006.

N. Mata, R. Alonso, and L. Badimon, Clinical characteristics and evaluation of LDLcholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART), Lipids Health Dis, vol.10, p.94, 2011.

, Scientific Steering Committee on behalf of the Simon Broome Register Group. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management, Atherosclerosis, vol.142, pp.105-112, 1999.

M. Benn, G. F. Watts, A. Tybjaerg-hansen, and B. G. Nordestgaard, Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication, J Clin Endocrinol Metab, vol.97, issue.11, pp.3956-64, 2012.

J. Versmissen, D. M. Oosterveer, and M. Yazdanpanah, Efficacy of statins in familial hypercholesterolaemia: a long term cohort study, BMJ, vol.337, p.2423, 2008.

I. K. Luirink, M. D. Albert-wiegman, M. D. Ph, D. Kusters, and M. D. , 20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia, N Engl J Med, vol.381, pp.1547-1556, 2019.

, Diagnostic et traitement des hypercholestérolémies familiales (HF) chez l'adulte : recommandations de la Nouvelle société française d'athérosclérose (NSFA)

D. J. Barker, The origins of the developmental origins theory, J Intern Med, 2007.

T. J. Roseboom, J. H. Van-der-meulen, A. C. Ravelli, C. Osmond, D. J. Barker et al., Effects of prenatal exposure to the Dutch famine on adult disease in later life: an overview, Mol Cell Endocrinol, vol.185, issue.1-2, pp.93-101, 2001.

J. Agot-lia-amundsen-?-a and . Khoury-b, Per Ole Iversen a, Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia, Atherosclerosis, vol.189, pp.451-457, 2006.

. Esc/eas, Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk, The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and

S. Béliard, F. Boccara, B. Cariou, and A. Carrié,

J. Farnier, M. Ferrières, N. Krempf, J. Peretti, M. Rabès et al., Alexandre Vimont, Sybil Charrière, Eric Bruckert, French FH Registry group, High burden of recurrent cardiovascular events in heterozygous familial hypercholesterolemia: The French Familial Hypercholesterolemia Registry, Atherosclerosis, vol.277, pp.334-340, 2018.

M. N. Anouk-van-der-graaf, D. Vissers, D. Gaudet, and . Brisson,

T. J. Sivapalaratnam, A. C. Roseboom, J. J. Jansen, . Kastelein, and A. Barbara,

. Hutten, Dyslipidemia of Mothers With Familial Hypercholesterolemia Deteriorates Lipids in Adult Offspring, Arterioscler Thromb Vasc Biol, vol.30, pp.2673-2677, 2010.

I. Narverud, J. Roeters-van-lennep, J. J. Christensen, and J. Versmissen,

M. Gran, P. Per-ole-iversen, B. Aukrust, T. Halvorsen, . Ueland et al., Kjetil Retterstøl, Kirsten B. Holven, Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemia, Atherosclerosis, vol.243, pp.155-160, 2015.

D. M. Kusters, H. J. Avis, M. J. Braamskamp, R. Huijgen, F. A. Wijburg et al.,

B. A. Wiegman and . Hutten, Inheritance pattern of familial hypercholesterolemia and markers of cardiovascular risk, J. Lipid Res, vol.54, pp.2543-2549, 2013.

J. Versmissen, P. G. Ilse, and . Botdena, Maternal inheritance of familial hypercholesterolemia caused by the V408M low-density lipoprotein receptor mutation increases mortality, Atherosclerosis, vol.219, pp.690-693, 2011.

C. Napoli, K. Christopher, . Glass, L. Joseph, and . Witztum, Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in 25 childhood: Fate of Early Lesions in Children (FELIC) study, THE LANCET ·, vol.354, 1999.

C. Napoli, F. Paolo-d'armiento, and F. P. Mancini,

J. L. Postiglione, G. Witztum, W. Palumbo, and . Palinski, Fatty Streak Formation Occurs in Human Fetal Aortas and is Greatly Enhanced by Maternal Hypercholesterolemia, J Clin Invest, vol.100, issue.11, pp.2680-2690, 1997.

W. Palinski, F. P. D'armiento, J. L. Witztum, F. De-nigris, F. Casanada et al., Maternal Hypercholesterolemia and Treatment During Pregnancy Influence the Long-Term Progression of Atherosclerosis in Offspring of Rabbits, Circ Res, vol.89, pp.991-996, 2001.

J. S. Welch, B. Bs;-federico, and P. Calara,

O. Robert,

C. K. Glass, . Md;-wulf, . Palinski, and . Md, Maternal Hypercholesterolemia During Pregnancy Promotes Early Atherogenesis in LDL Receptor-Deficient Mice and Alters Aortic Gene Expression Determined by Microarray, Circulation, vol.105, pp.1360-1367, 2002.

A. J. Lewandowski and M. Lazdam,

J. Francis, S. Neubauer, A. Singhal, A. Lucas, B. Kelly et al., Short-Term Exposure to Exogenous Lipids in Premature Infants and Long-Term Changes in Aortic and Cardiac Function, Arterioscler Thromb Vasc Biol, vol.31, pp.2125-2135, 2011.

C. Hsu and Y. Tain, The Good, the Bad, and the Ugly of Pregnancy Nutrients and Developmental Programming of Adult Disease, Nutrients, 2019.

C. Trenteseaux, A. Gaston, A. Aguesse, G. Poupeau, P. De-coppet et al., Perinatal Hypercholesterolemia Exacerbates Atherosclerosis Lesions in Offspring by Altering Metabolism of Trimethylamine-N-Oxide and Bile Acids, Arterioscler Thromb Vasc Biol, vol.37, pp.2053-2063, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02429561

J. Qi, T. You, J. Li, T. Pan, L. Xiang et al., Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and metaanalysis of 11 prospective cohort studies, J. Cell. Mol. Med, vol.22, issue.1, pp.185-194, 2018.

B. J. Bennett, T. Q. De-aguiar, Z. Vallim, D. M. Wang, and . Shih,

J. Meng, H. Gregory, R. Allayee, M. Lee, R. Graham et al.,

S. L. Edwards, A. J. Hazen, and . Lusis, Trimethylamine-N-Oxide, a Metabolite Associated with Atherosclerosis, Exhibits Complex Genetic and Dietary Regulation, Cell Metab

, January, vol.8, issue.1, pp.49-60

A. M. Deaton, P. Sulem, and P. Nioi, A rare missense variant in NR1H4 associates with lower cholesterol levels, Commun Biol, vol.1, p.14, 2018.

S. Byun, H. Jung, J. Chen, Y. Kim, D. Kim et al., Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis, J. Biol. Chem, 2019.

G. S. Berenson, R. Sathanur, W. Srinivasan, W. P. Bao, R. E. Newman et al., for the Bogalusa Heart Study. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults, N Engl J Med, vol.338, pp.1650-1656, 1998.

B. G. Nordestgaard, Lipoprotein(a) as a cardiovascular risk factor: current status, European heart journal
URL : https://hal.archives-ouvertes.fr/inserm-00578888

C. Waldeyer, N. Makarova, T. Zeller, R. B. Schnabel, and J. Fabian,

T. Brunner, A. Jørgensen, and . Linneberg,

J. Jousilahti, M. M. Yarnell, G. Ferrario, P. Veronesi, . Brambilla et al.,

L. Signorini, S. Iacoviello, S. Costanzo, L. Giampaoli, and . Palmieri,

B. Meisinger, F. Thorand, W. Kee, F. Koenig, J. Ojeda et al., Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium, European Heart Journal, vol.38, pp.2490-2498, 2017.